ML
SYNH

McAdam LLC’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

McAdam LLC’s Portfolio SYNH Stock Details SYNH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-37
Closed -$1K – 849
2018
Q1 		$1K Buy
+37
New +$1.45K ﹤0.01% 724

Other funds holding SYNH

THLTP
Thomas H. Lee (THL) Partners Boston, Massachusetts $205M AUM 1.84% 1-Year Est. Return
AI
Advent International Boston, Massachusetts $4.24B AUM 4.24% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

McAdam LLC's SYNH Position: Q2 2018 in Review

McAdam LLC sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q2 2018, closing a stake of 37 shares — an estimated $1K sold.

McAdam LLC first reported a position in SYNH in Q1 2018 and held it in 1 quarter. The position peaked at $1K in Q1 2018. 213 funds tracked by Wall St. Rank hold SYNH as of Q2 2018.

  • McAdam LLC reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q2 2018 after selling out during the quarter.
  • McAdam LLC sold 37 Syneos Health, Inc. Class A Common Stock shares in Q2 2018, an estimated $1K.
  • McAdam LLC first reported a position in Syneos Health, Inc. Class A Common Stock in Q1 2018 and held it in 1 quarter.
  • McAdam LLC's Syneos Health, Inc. Class A Common Stock position peaked at $1K in Q1 2018.
  • 213 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q2 2018.

Based on McAdam LLC's 13F filing for Q2 2018, filed 22 Aug 2018.